30 December 2013
: Case report
ANCA-positive vasculitis induced by levamisole-adulterated cocaine and nephrotic syndrome: The kidney as an unusual target
Challenging differential diagnosis, Unexpected drug reaction, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Hortensia Álvarez DíazABDEF, Ana Isabel Mariño CallejoABD, José Francisco García RodríguezABD, Laura Rodríguez PazosABD, Inmaculada Gómez BuelaABD, Ana María Bermejo BarreraABDDOI: 10.12659/AJCR.889731
Am J Case Rep 2013; 14:557-561
Abstract
Background: Levamisole has been detected in seized cocaine samples and a levamisole-induced vasculopathy (LIV) has been described, mainly focused on skin.
Case Report: A 36-year-old Caucasian man with history of antibodies to hepatitis C infection (negative hepatitis C virus RNA and negative HIV serology), smoking, and intravenous use of cocaine and brown heroin, presented to the hospital with purpuric skin lesions on extremities and earlobes. One month before the current presentation, a skin punch biopsy of one of these lesions was performed, showing histopathologic findings suggestive of mixed cryoglobulinemia. Laboratory testing revealed leukopenia, renal failure, and nephrotic syndrome. Antimyeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) were positive. The previous skin punch biopsy was revised and demonstrated pathologic findings consistent with leukocytoclastic vasculitis. An analysis of a cocaine sample for personal use, provided by the patient, was performed using mass spectrometry-gas chromatography and levamisole was detected. Three boluses of intravenous methylprednisolone were administered, followed by oral prednisone 1 mg/Kg per day. Skin lesions and renal function improved.
Conclusions: To our knowledge, this is the first report of nephrotic syndrome induced by levamisole-adulterated cocaine, proven by cocaine sample toxicology. Lack of renal biopsy is a limitation of this report.
Keywords: nephrotic syndrome, Vasculitis, Cocaine, Levamisole
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946727
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946839
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946674
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945853
Most Viewed Current Articles
21 Jun 2024 : Case report
96,182
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,159
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,026
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,365
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030